How Duke-NUS Medical School supports staff to drive healthcare innovations
BRANDED CONTENT 'Our role is about service': Why staff stay, grow and drive healthcare innovation at this med school Duke-NUS Medical School's culture of open collaboration and access to a vast clinical ecosystem enables its staff to push boundaries in medicine and public health
From installing life-saving devices at Housing Board void decks to discovering new cancer treatments, innovation at Duke-NUS Medical School extends beyond the lab.
In March 2025, in collaboration with SingHealth, the school launched its Artificial Intelligence in Medicine Institute (AIMI) with the aim to equip healthcare professionals with the tools and support to develop and apply AI solutions in the real world.
There is tremendous use for AI, from finding new drugs to understanding complex biological pathways, to detecting patterns in the emergence of diseases, says Professor Patrick Tan, Duke-NUS' senior vice-dean for research.
A Stanford-trained MD (Doctor of Medicine)-PhD holder, the 56-year-old was one of the school's pioneer faculty members and has been appointed the next and fourth dean of the school, effective January 1, 2026.
'The character of Duke-NUS is very special,' he says. 'We're a medical school that produces doctors who do more than clinical care, researchers who do more than publish papers, and administrators who lean into our mission of innovative education and impactful research that transforms the practice of medicine in Singapore and beyond.'
This sense of shared purpose is echoed by Associate Professor Shiva Sarraf-Yazdi, who sums it up succinctly: 'Our role is about service.'
Duke-NUS was established in 2005 as a partnership between two world-class institutions: Duke University and the National University of Singapore.
A former Duke-trained surgeon, she joined Duke-NUS more than a decade ago to focus on medical education. 'The act of surgery itself measures impact in days, weeks or months but education measures impact in decades,' says the 53-year-old, who is now the vice-dean for education overseeing the Duke-NUS MD programme.
The school has been ranked as one of Singapore's best employers for five years running, in a list compiled by global research firm Statista in collaboration with The Straits Times. Faculty members and staff have cited a high level of trust, strong emphasis on workplace diversity and clear work expectations as factors that make Duke-NUS stand out as an employer.
Prof Tan, who leads a 600-strong research office, says: 'Part of my job is to bring in the best people, assemble the best teams, and make sure they can do their best work with supporting structures in place to tackle the big questions of the future.'
The setting up of AIMI marks the school's latest move to leverage cutting-edge technology and interdisciplinary expertise to solve complex healthcare challenges and redefine what's possible in patient care.
A spirit of innovation at Duke-NUS Medical School empowers every member to push boundaries, to transform medicine and improve lives. (Seated, from left) Professor Patrick Tan, senior vice-dean for research; professor Thomas Coffman, dean; and Dr Zhou Jin, principal research scientist. (Standing, from left) Mr Anirudh Sharma, director, communications and strategic relations; and associate professor Shiva Sarraf-Yazdi, vice-dean for education.
PHOTO: DUKE-NUS MEDICAL SCHOOL
Creating real-world impact
Prof Tan says the scale and success of the work of Duke-NUS researchers is made possible because of the institution's collaborative model and access to Singapore's broader healthcare ecosystem.
That includes his own groundbreaking contributions to stomach cancer research.
Prof Tan's work in gastric cancer won the American Association for Cancer Research Team Science Award in 2018 – a first for a team from Asia.
Supported by Duke-NUS, his team – comprising researchers from the National Cancer Centre Singapore, the Genome Institute of Singapore and collaborators from Japan, Taiwan and Thailand – identified key genetic abnormalities in stomach cancers and translated those findings into targeted clinical trials.
Reflecting on his focus on research rather than clinical care, he says: 'When you provide clinical care, it is to one patient at a time. This is tremendously important. But if you can find the cause of disease and therapy to intervene, there is a much broader level of impact.'
Another real-world example is the installation of AEDs (Automated External Defibrillators) across Singapore, an initiative led by Duke-NUS' research on out-of-hospital cardiac arrest survival rates.
'It wasn't a drug, but it saved lives. That's the impact,' says Prof Tan.
Breakthroughs in medical research and healthcare Fighting cancer
From developing Singapore's first home-grown cancer drug (ETC-159) to mapping stomach tumours for personalised therapies, scientists at Duke-NUS are leading advances in cancer treatment.
From developing Singapore's first home-grown cancer drug (ETC-159) to mapping stomach tumours for personalised therapies, scientists at Duke-NUS are leading advances in cancer treatment. Pioneering Covid-19 response
Duke-NUS is among the first globally to isolate, culture and characterise the SARS-CoV-2 virus, driving innovations in Covid-19 testing, vaccines and therapeutics – including the world's first FDA-approved neutralising antibody test kit.
Duke-NUS is among the first globally to isolate, culture and characterise the SARS-CoV-2 virus, driving innovations in Covid-19 testing, vaccines and therapeutics – including the world's first FDA-approved neutralising antibody test kit. Hope for Parkinson's
Duke-NUS is advancing cell therapies for brain diseases like Parkinson's, taking these treatments from the lab to clinical trials in Singapore and overseas.
Duke-NUS is advancing cell therapies for brain diseases like Parkinson's, taking these treatments from the lab to clinical trials in Singapore and overseas. Driving longevity research
Researchers at Duke-NUS discovered how the IL-11 protein is linked to ageing and excess scar tissue build-ups in organs or tissues, paving the way for new treatments.
Researchers at Duke-NUS discovered how the IL-11 protein is linked to ageing and excess scar tissue build-ups in organs or tissues, paving the way for new treatments. Beating cardiac arrest
Research led to the placement of over 10,000 automated external defibrillators across Singapore and cardiopulmonary resuscitation training for more than 180,000 people annually – dramatically improving survival from cardiac arrests outside hospitals.
Empowering bold innovations
Prof Sarraf-Yazdi feels the school's innovation-friendly culture encourages bold ideas.
This support has enabled her team to embark on new projects that continually enhance the school's education programme to better prepare students for clinical practice.
One of her earlier initiatives was the MD Programme Longitudinal Integrated Clerkship. It was run as a pilot to expose students to multiple clinical disciplines in a holistic approach while enabling them to form stronger connections with patients, mentors and peers.
Insights from the pilot helped reshape the MD curriculum, such as the longitudinal C.A.R.E. (Connect, Assimilate, Reflect, Explore) Programme, which now spans the entire curriculum. The programme complements students' capabilities for practice by progressively incorporating essential skills like communication, clinical reasoning, ethics and professionalism, while exploring emerging healthcare priority areas such as Population Health and AI in medicine.
Associate Professor Shiva Sarraf-Yazdi with Duke-NUS students during one of their clinical education programmes, practising procedural skills in a safe environment.
PHOTO: DUKE-NUS MEDICAL SCHOOL
'It is easy to take bold steps when you are backed by a courageous team and supported by institutional leadership that tolerates failure, embraces change and encourages innovation,' she says.
In addition to Duke-NUS, she credits the school's extended ecosystem – including over 2,000 clinical faculty across the SingHealth Duke-NUS Academic Medical Centre – for guiding students through their clinical education.
Enduring impact on public health
At Duke-NUS, professional growth is not limited to students. By providing a supportive environment including flexible work arrangements to encourage lifelong learning, faculty and staff are enabled to deepen their expertise and expand their capabilities.
Prof Sarraf-Yazdi herself pursued two additional degrees while working – a Master of Health Professions Education from Johns Hopkins University and a Master of Business Administration from NUS.
Programmes such as the Dean's Excellence Awards and Administrative Achievement Awards also help in highlighting staff contributions and fostering peer appreciation.
Prof Tan says: 'There is an ethos and culture to Duke-NUS that has sustained me.
'Here, you will find that many of us stay for quite a long time because we're all attracted to this very dynamic place that tackles some of the key and important questions of the future that affect Singapore and the world.'
Read more about Singapore's Best Employers 2025.
Join ST's WhatsApp Channel and get the latest news and must-reads.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
2 days ago
- Straits Times
Life After... blazing biomedical research trail in S'pore: Renowned scientist breaks new ground at 59
Sign up now: Get ST's newsletters delivered to your inbox So much of the news is about what's happening in the moment. But after a major event, people pick up the pieces, and life goes on. In this new series, The Straits Times talks to the everyday heroes who have reinvented themselves, turned their lives around, and serve as an inspiration to us all. World-renowned nanotech scientist Jackie Ying moved to Saudi Arabia in 2023 to help further the country's biomedical research potential. SINGAPORE - Professor Jackie Ying, a pint-sized dynamo never seen without her signature headscarf, dark suit and track shoes, has always lived life on her terms. As she approaches 60, she has again met change head-on. The world-renowned nanotech scientist has relocated from Singapore – where she spent two decades as one of the pioneers transforming the nation into a research powerhouse – to Saudi Arabia. Prof Ying has given up all she has accomplished here to move to the Middle East, where she is building a laboratory in Saudi Arabia's capital Riyadh to advance novel diagnostics and treatments in genetic diseases, which are particularly prevalent there. It is yet another milestone in a career of many firsts for the Taiwan-born, US-trained scientist. 'I'm really excited. I feel 20 years younger because of all these new things I want to do,' she told The Straits Times. 'Physically, I think I'm running after myself because of the excitement of my lab and the collaborators.' Top stories Swipe. Select. Stay informed. Singapore First BTO project in Sembawang North to be offered in July HDB launch World Tariffs will kick in on Aug 1 barring trade deals: US Treasury Secretary Singapore Woman on SMRT's 190 bus injured after bottle thrown at vehicle leaves hole in window Business Great Eastern says Takeover Code not breached when it shared IFA valuation with OCBC Asia 'Don't be seen in India again': Indian nationals pushed into Bangladesh at gunpoint Asia Thousands evacuated as Typhoon Danas lashes Taiwan Asia Two women fatally stabbed at bar in Japan by man Life Star Awards 2025: Christopher Lee wins big, including Special Achievement Award and Best Actor The plan is to help advance Saudi Arabia's budding biomedical scene, as Prof Ying did for Singapore many years ago. Blazing a trail in Singapore Prof Ying, 59, is among a pool of top researchers, coined 'whales', who were wooed here from all over the world more than two decades ago by then A*Star chairman Philip Yeo to turn Singapore into a biomedical hub. Among other achievements, she helped to establish Biopolis. One of the youngest people to make full professor at the Massachusetts Institute of Technology (MIT) at the age of 35, she moved to Singapore in 2003 to become the founding director of A*Star's Institute of Bioengineering and Nanotechnology (IBN), which has since been merged with a consortium to form the A*Star Institute of Bioengineering and Bioimaging. In 2018, Prof Ying and her team built A*Star's NanoBio Lab, a research incubator, from scratch. Prof Ying is a master of building materials thinner than a strand of hair which can be harnessed in areas as varied as medicine, chemistry and energy. She has helped to build more than 13 start-ups, invented and patented hundreds of technologies, and won numerous awards. Among her inventions are a device that can test for dengue within 20 minutes with just saliva, and tiny particles that automatically deliver insulin to diabetic patients when their blood glucose levels are high. One of her start-ups, Cellbae, developed the first made-in-Singapore antigen rapid test kits for Covid-19, which were subsequently exported to Europe. With her many awards and accolades, Prof Ying is a well-known figure in Singapore, and is often approached by strangers for photographs when she is in the country. But her last few years working in Singapore were not easy, she said, as leadership changes led to major changes that impacted various institutes under A*Star. Without divulging details, she said: 'We didn't have the same level of independence as what we used to have, and that really affected our smooth operations.' In mid-2023, Prof Ying was invited to become a visiting distinguished professor and senior adviser to the president of the King Fahd University of Petroleum and Minerals in Saudi Arabia, which had just formed a bioengineering department. The move took substantial courage Moving to a new environment was not an easy decision because of her strong ties with Singapore, admitted Prof Ying. She lived in Singapore as a child and studied at primary and secondary schools here when her father, who taught Chinese literature, was a faculty member at the former Nanyang University. But she took the leap, and moved to Saudi Arabia in 2023. 'I also looked at potentially returning to the US, but this possibility opened up in Saudi Arabia, and I think that was far more exciting... something different in another continent,' said Prof Ying. 'It was a very difficult decision to leave Singapore. Our lab was very nicely established, and blessed with excellent staff who have worked with me for many years. It was very painful to leave them; they are like family members,' she added. Now, while she is with King Fahd University, her main appointment is head of the bioengineering and nanomedicine department of King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh. In less than two years , she has set up the foundations of her new office: a 1,500 sq m lab – the size of more than 10 four-room Housing Board flats. 'We have received major funding internally from KFSHRC to build a large, new lab with lots of state-of-the-art equipment. We have successfully recruited over a dozen research staff and students in a year, and will continue to grow in the coming years,' said Prof Ying. Professor Jackie Ying treats her researchers in Singapore like family, and in Saudi Arabia, she does the same. PHOTO: KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE 'I find I'm just racing (against) time to get as much done as possible. In your 50s, to make a major change in your working environment, especially in one that has been so productive, took substantial courage,' she said. On a mission to tackle Arab world's genetic diseases The doors to Saudi Arabia opened wide for Prof Ying in 2023 when she became the first woman to receive what is known as the 'Arab Nobel prize' – the King Faisal Prize in Science for her work in nanomedicine. Some past laureates have gone on to win a Nobel Prize. At the same time, research received a boost as pursuing biotechnology and improving public health became a focus area under the Saudi Vision 2030 – a government push to diversify the Saudi Arabian economy beyond oil and gas. The kingdom had recently set out a strategy to advance its self-sufficiency in vaccines, biomanufacturing and genomics. Prof Ying is particularly interested in tackling genetic diseases. People in the Middle East and North Africa region have a malaise of inherited disorders – higher than the global average – a result of the cultural practice of marrying within tribes. Walking up to her lab in the hospital, she sees children in wheelchairs – afflicted with cancers such as leukaemia and neurological diseases such as spinal muscular atrophy, a rare disorder that causes muscle weakness and breathing problems. 'The doctors will be knocking on your door; they are anxious to do research. We see the frustrations some clinicians have when it comes to genetic diseases. They know what their patients are suffering, but there's a lack of therapies that are effective and affordable,' said Prof Ying. Her team is working on identifying genetic clues called biomarkers that indicate the presence of a disease. New gene therapies can then be developed to attack the disease-causing biomarkers. For example, her team is developing man-made patches of DNA that attach to molecules that produce disease-causing proteins and block their production. This is a form of RNA (ribonucleic acid) therapy. 'Using machine learning and artificial intelligence, we hope to accelerate the creation of effective RNA therapies that could be much less expensive than the available DNA therapies, which can cost over $2 million for a patient with spinal muscular atrophy,' said Prof Ying. She added: 'KFSHRC specialises in the most challenging diseases. In the region, patients with complicated diseases will flock to the hospital. Access to the patients really helps with biomarker discovery and clinical trials.' She is also keen on tracking emerging infectious diseases, and her lab is collaborating with Cellbae to monitor wastewater for traces of viruses at hospitals, farms and religious sites. 'A citizen of the world' In early 2025, Prof Ying was appointed to lead research and innovation at KFSHRC, which has three main hospitals in the kingdom. 'I'm really trying my best because I'm at a certain age. I really want to see this happen. But more importantly, I want to train the students, those doing their PhD, and the more senior people, so that they can front a lot of things.' Prof Ying, who has a 23-year-old daughter pursuing a dual doctorate in medicine and scientific research at Texas A&M University, said she takes pride in nurturing many young researchers who pass through the doors of her labs. Several of her former A*Star colleagues from IBN and her NanoBio Lab have followed her to Saudi Arabia. The move was not easy for some, who have young families in tow, added Prof Ying. One of them is Dr Muhammad Nadjad Abdul Rahim, who was Prof Ying's PhD student back in the NanoBio Lab, which has since closed down. Prof Jackie Ying and her Cellbae colleagues Muhammad Nadjad Abdul Rahim (looking through microscope) and Kian Ping Chan, both of whom recently moved to Riyadh. PHOTO: KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE Dr Nadjad, 37, is now operations and product development director of Cellbae, which expanded to Saudi Arabia in 2024. It was founded in Singapore with another branch in the US. In addition to producing Covid-19 test kits, Cellbae creates test kits for various pathogens, and for food and environmental monitoring, and other medical devices. The company is looking at improving diagnostics for genetic diseases and cancers that are more pronounced in the kingdom, like Hodgkin's lymphoma – an aggressive form of blood cancer that is increasingly afflicting young people there. It is also developing a method to amplify signatures of virus families so that scientists can keep an eye on circulating diseases in wastewater. Said Dr Nadjad: 'Prof Ying doesn't sleep enough. Our team has no idea how she finds that energy. But I think this is encapsulated in her belief of how hard we must work to solve problems in the world.' Commenting on Prof Ying's move to Saudi Arabia, he added: 'A scientist is a citizen of the world. She is always rolling up her sleeves to solve difficult problems and not one who would be comfortable sitting down collecting salary.' Prof Ying, a devout Muslim who has been to Mecca in Saudi Arabia more than 15 times to perform the haj and umrah pilgrimages, said she has fit in well in her new home. Born into a Christian family, she converted to Islam in her 30s. 'There is this notion that Saudi Arabia has issues with human rights. I have told others: 'Please come and see for yourself.' Over the last few years, I would say people are very well treated – women or men, it doesn't matter. It's a very safe, very secure, very peaceful place,' she said. 'I love living here. Riyadh is a dynamic and rapidly growing city, with lots of great restaurants.' Working harder as a minority In the light of her many achievements, it can be hard to remember that the odds were stacked against Prof Ying, who has been known to call herself a 'minority of minorities', as a Chinese Muslim female in the male-centric world of science. In the early 1990s, she was the first female Asian American professor at the MIT School of Engineering, and the lecture hall blackboards were not built for those with a smaller stature. 'I could only reach the bottom half of the lowest blackboard. After writing just a few equations, I had to erase them because I couldn't reach the higher blackboards,' she said with a laugh. In the locker room of her New York high school – famous for being where folk rock duo Simon and Garfunkel first started performing together as students – a couple of taller teenage girls would stare her down to intimidate her. 'I wouldn't say it was bullying, but there are people who are not particularly friendly. You go to high school through metal detectors. I wouldn't say students were carrying guns, but some of them certainly had knives,' she said. Those moments helped her build grit. 'As a minority, I told myself I've got to work twice as hard.' And she did. In 2017, she received the highest accolade for academic inventors as a fellow of the US National Academy of Inventors. And each year since 2012, she has been listed among the world's 500 most influential Muslims. 'It's important to speak up despite being a minority. I am not a yes-man and don't expect my staff to be yes-men,' she said. Looking ahead towards the next phase of her career in the kingdom, Prof Ying said: 'It's a lifetime of work ahead. We always pray hard and wish for good health and abundant resources.'
Straits Times
6 days ago
- Straits Times
NUS Medicine's target? To be world's top medical school for Asia
Sign up now: Get ST's newsletters delivered to your inbox The NUS Yong Loo Lin School of Medicine has come far in 120 years. The Straits Times takes a look at some of its achievements and where it is headed. NUS Yong Loo Lin School of Medicine's dean, Professor Chong Yap Seng, wants the school to lead the world in advancing health beyond the treatment of disease. SINGAPORE – The NUS Yong Loo Lin School of Medicine is one of the world's best medical schools – and it is not the one saying it. For the past six years, it has ranked among the world's top 20 medical schools in the Times Higher Education World University Rankings – at 17th in 2025. In 2024 and 2025, it ranked 18th in the QS World University Rankings for medicine . But the school's dean, Professor Chong Yap Seng, wants more than that. He wants it to become the world's leading medical school to represent Asia on the global stage. He said the school is well-positioned to produce Asia-contextualised research and knowledge to develop solutions that are relevant and effective for Asian communities. The top medical schools in the world today are largely American or European, and they cannot be counted on to understand and research Asian patterns of disease. This is reflected in medical literature that is based on Western perspectives and derived from Western research efforts. Prof Chong wants to demonstrate that NUS Medicine and Asia can lead in setting new standards for medical education, research, health and healthcare, and most importantly, to be able to shape the future of global health. He aims to do that by focusing the school's efforts on optimising health, moving beyond the treatment of disease and truly leveraging digital technology, data and artificial intelligence to unlock the value of health data. This is not simply to have a claim to fame, he insisted. 'Asians are quite different in the way they respond to drugs.' As an example, he cited warfarin, a common blood thinner used to prevent blood clots that could cause strokes or heart attacks. 'If you give the normal dose for Caucasians to Singaporeans, they will probably bleed to death,' he said. Asians need, on average, half to two-thirds the dose given to Caucasians. The medical school, which was started 120 years ago to train locals as assistants to colonial doctors, is ready to come into its own as the premier institution focusing on how diseases and treatments affect Asian populations differently, Prof Chong said. Singapore is well poised to lead research in this area, having completed the whole genome sequencing of 100,000 locals, and having started on the genomes of another 450,000 patients with known diseases. Some of the research has already improved outcomes for the population. An ongoing longitudinal study begun by Prof Chong in 2009 has helped hundreds of women and their babies by identifying gestational diabetes and treating it early in pregnant women, thus avoiding serious complications. The Growing Up in Singapore Towards Healthy Outcomes (Gusto) study found that one in five Asian women, even those without risk factors such as being overweight, suffers from gestational diabetes – double the rate in Caucasian women. Because of Gusto's findings, pregnant women are now routinely checked for this complication. Prof Chong's aspiration has not been without criticism that he is over-valuing rankings, but he argued it is not a vanity project. 'Actually, it is business. It is partly recognition, partly achievement, but also partly business. If you are not among the top, people don't really want to work with you,' he asserted. In March, the school signed a memorandum of agreement with the Harvard T.H. Chan School of Public Health on a women's health initiative. Ten years ago, said Prof Chong, Harvard – one of the world's top universities – might not even have agreed to meet him. 'The ability to be among the top in the world gives you the ability to work with the best people in the world. We have their full attention, which is very important for us to really make progress,' he said. Global ranking is based on many factors, such as an institution's international research networks, how often published articles by faculty are cited by others, the amount of grants it receives, and the quality of its education. Prof Chong focused on driving up citations by increasing the quality of the school's research and publications. 'If we want to be world-class, we have to compete on the world stage in terms of quality and impact. If you are very well-cited, it means that your work is influencing other people and is driving the science,' he said. As a result, NUS Medicine's citation impact has gone up from 1.68 when he took over as dean in 2019, to 2.59 in 2024. The citation impact reflects the prestige of the article, with 1 signifying an average number of citations, and 2 meaning that the article has been referred to twice as often. This even includes research published by students. For example, a study on gastric cancer by fifth-year student Joseph Zhao was published in 2022 in the Journal of Clinical Oncology, which had a very high impact factor of 45 in 2024. A study on liver cirrhosis by another fifth-year student, Ms Lim Wen Hui, was published in 2023 in the Journal of Hepatology which boasts an impact factor of 26.8. An impact factor of 10 or higher is considered remarkable for medical journals. To drive up citations, the medical school has been hiring quality researchers from around the world who do impactful work, with the potential to make significant contributions to the school's research goals. Another change Prof Chong has instituted is to refocus medical training, from treating diseases to prolonging good health in people. He said: 'Every medical school is good at diagnosing and managing diseases. I believe that a medical school should go beyond disease. So we are now looking at health.' Life expectancy in Singapore has risen over the past decades, and people here are among those who live longest in the world today. But the increase in years of good health has not kept pace, he said. 'We have to start looking at health span. What can we do to extend that?' He added: 'What I'm interested in is how long I can keep you healthy so that when you finally have a disability and start to experience frailty, that part is as short as possible.' In pursuit of that aspiration, Prof Chong plans to introduce lifestyle medicine into the undergraduate curriculum, to focus on the four things that drive health: nutrition, physical activity, sleep and purpose. Purpose in life is important, he noted. 'If people don't have a good reason to do what they're doing, or feel that what they're doing is not important, they won't maintain their health, and they won't have mental clarity. People who lose purpose in life, for example after retirement, often lose their health and die earlier,' he said. One change he has already made to the curriculum to prepare graduates to perform well into the 21st century is to make bioinformatics and artificial intelligence a compulsory minor subject. All students enrolled from 2023 have to take this as a minor subject in their first three years. With health data accounting for 30 per cent of all data produced in the world, it is crucial that doctors can understand and interpret it , to improve the care they give to patients, Prof Chong said. As an example, he cited a check in 2016 conducted by one of the school's cardiologists, Associate Professor James Yip, on which drug the department spent the most money on in treating patients. To Prof Yip's shock, instead of a heart-related drug, the largest expenditure was on proton pump inhibitors (PPIs) such as omeprazole, which is used to prevent gastric ulcers. Doctors prescribe such medication to patients alongside aspirin, which is known to be damaging to the gastric wall. But Prof Chong said the aspirin prescribed is usually a low dose, and rarely causes ulcers. Instead of the more expensive PPI, a low-cost antacid would do. Since this discovery, there has been a conscious effort to reduce the use of PPIs, resulting in a 10 per cent drop in prescriptions. Prof Chong said another example of medical school dogma, rather than new data, influencing prescriptions is the low uptake of SGL T-2 inhibitors, a medication that had become standard of care for diabetics and early-stage kidney and heart failure patients in 2017 – as it can reduce the risk of kidney and heart failure. Despite the Ministry of Health providing subsidies for this drug, fewer than half of patients who could benefit are prescribed the medication. Prof Chong said doctors continue to prescribe drugs they are familiar with, instead of switching to better drugs as they become available, because they may not understand the data supporting the new drug. He said there are now plans to use information technology to prompt doctors at specialist outpatient clinics within the National University Health System (NUHS) cluster to prescribe it to eligible patients. 'Doctors really need to master data, because that's the future,' he added. 'All data will be available digitally. It's a waste that they don't use it. If our doctors are not equipped to use it, they will be less effective compared with the doctors of other places who use it.' Looking back on NUS Medicine's long history, Prof Chong said the 120 years fall roughly into four major phases. In 1905, when the school was opened, almost one in three children born here died before the age of one. The focus at the time was to provide medical care and improve public health. The second phase in the 1950s was when it gained a reputation as a good medical school, attracting 'the best students from Asia' to study here. The third phase, occurring around the cusp of the millennium, is when it turned its eyes towards research. For the past six years, the NUS Yong Loo Lin School of Medicine has ranked among the world's top 20 medical schools in the Times Higher Education World University Rankings – at 17th in 2025. PHOTO: NUS Professor Tan Chorh Chuan, a nephrologist by training who was dean from 1997 to 2000, made major reforms to the school's curriculum with an emphasis on research. He later continued his push to make both the school and the National University of Singapore research-intensive in his roles as the university's senior deputy president (2004 to 2008) and president (2008 to 2017). The Government's Biomedical Sciences Initiative in 2000 also fuelled Singapore's research boom. NUS Medicine started recruiting the best scientists they could find and establishing international research collaborations. The school geared up to attract global talent, aiming for better funding opportunities, developing world-class infrastructure, and fostering collaborations across academia, healthcare and industry. In 2005, it received $100 million from the Yong Loo Lin Trust – the largest single donation to a tertiary institution by a private donor. This was Professor John Wong's doing, said Prof Chong. Prof Wong, an oncologist-haematologist, was dean from 2003 to 2011. Professor Yeoh Khay Guan, who was dean from 2011 to 2018, strengthened the clinician-scholar and clinician-scientist tracks. A noted researcher, he was listed among the world's top 2 per cent of scientists by Stanford University in 2023 in the field of clinical medicine. One of his most prominent research projects is the Singapore Gastric Cancer Consortium, which has made several breakthrough discoveries in diagnosing the cancer early. Prof Yeoh, who is a gastroenterologist, currently holds the position of chief executive at NUHS. Prof Chong has moved the school into its fourth phase: to transform the practice of medicine to focus more on preserving health rather than just treating illness. As the school celebrates 120 years, he hopes his legacy as dean will be to have made a difference that matters. For him, this means making the school the best in terms of understanding and treating Asians, and for the doctors it trains to practise intellectual flexibility, be technology-savvy and have lifelong curiosity. From wooden hut to top 20 in the world In 120 years, NUS Medicine has grown from providing basic medical care to becoming a research-intensive medical school focused on cutting-edge medicine. 1821 Singapore's first general hospital is an unsanitary small wooden building near the junction of Bras Basah and Stamford roads, offering basic treatments. 1905 A new school of medicine to train locals opens at Sepoy Lines (the current site of the Singapore General Hospital) with 23 students. Merchants led by Mr Tan Jiak Kim and Mr Seah Liang Seah raise $87,000 in 1905 and another $120,000 in 1912. The Straits Settlements and Federated Malay States Government Medical School, Sepoy Lines. PHOTO: NUS 1910 Seven local medical students are the first to obtain Licentiates in Medicine and Surgery. The Magnificent 7 become assistant medical officers or assistant surgeons, earning a lowly $250 a month. A pioneering class with a Licentiate in Medicine and Surgery standing behind teachers. PHOTO: NUS 1911 Ms Eugenie Nunes becomes the first woman graduand, but she returns to Pakistan on graduating. 1912 Physiology is the first professorial chair to be set up. 1916 A medical students' hostel is set up to accommodate students from Malaya. 1932 Asians, considered inferior by the colonial government, are finally allowed to take positions in the Straits Settlements Medical Service. Mid-1930s Dr Gopal Haridas is the first local graduate to receive further training in England and admitted as a member of the Royal College of Physicians. Dr Michael Thiruchelvam is the first local graduate to obtain higher qualification in surgery. 1936 A huge bungalow on Grange Road, called Holne Chase, is converted into a hostel for 30 female students. 1941-1945 During World War II, more than 200 medical students join the Medical Auxiliary Service and are deployed to hospitals and first aid posts, often working 18 hours a day. 1942 Tan Tock Seng Hospital is bombed on Feb 13, killing medical student Yoong Tatt Sin. Another 10 medical students are killed the following day at his funeral. The medical school closes. 1946 The King Edward VII College of Medicine reopens on June 17, following the war. About 200 pre-war students return to complete their studies. King Edward VII College of Medicine. PHOTO: NUS 1950 The newly formed University of Malaya confers the first Bachelor of Medicine and Bachelor of Surgery (MBBS) on 17 graduates at the Bukit Timah campus. 1957 The Academy of Medicine is founded, paving the way for formal postgraduate training and continuing education. 1962 Singapore establishes the University of Singapore, with Professor Kangaratnam Shanmugaratnam as the medical school's dean. Professor Kangaratnam Shanmugaratnam. PHOTO: NUS 1980 The university officially becomes the National University of Singapore, in Kent Ridge, after a merger with Nanyang University. 1983 The Faculty of Medicine relocates from Sepoy Lines to Kent Ridge. 1985 The University Hospital (precursor to the National University Hospital) is set up as a government-owned hospital run as a self-governing entity. This is the model for all public hospitals today. 1994 The National Medical Research Council is set up to oversee, coordinate and approve funds for medical research. The White Coat Ceremony is introduced to induct medical students into the fraternity. Faculty members help incoming students don their first white coats, a symbol of physicians. A White Coat Ceremony held in 2024. PHOTO: NUS 2002 The government-imposed quota of no more than a third of medical students be women is lifted, resulting in an immediate jump in female students to 43 per cent of intake in 2003. 2005 Duke-NUS Medical School is set up. So is the Alice Lee Centre for Nursing Studies, with a $30 million gift from the Lee Foundation. The Faculty of Medicine is renamed the Yong Loo Lin School of Medicine on the school's centenary with a $100 million gift from the Yong Loo Lin Trust. 2008 The National University Health System (NUHS, below) is established to integrate and improve education, research and the provision of healthcare. The NUHS Tower Block at Kent Ridge Road in a photo taken on June 17, 2025. ST PHOTO: GAVIN FOO 2011 A $30 million donation from NUS alumnus Professor Saw Swee Hock (below) leads to the setting up of the Saw Swee Hock School of Public Health. Professor Saw Swee Hock. PHOTO: ST FILE 2012 The 15-storey Centre for Translational Medicine is officially opened. The Silent Mentors programme is initiated, with students taught to treat donated cadavers with utmost respect. 2014 The Centre for Biomedical Ethics is designated a World Health Organisation collaborating centre – the first in Asia and 5th in the world. 2019 School ranked among top 20 in the world – a ranking it maintains today. The NUS Yong Loo Lin School of Medicine Building on Medical Drive in a photo taken on July 17, 2019. PHOTO: ST FILE 2025 Yong Loo Lin Medical School celebrates 120 years.
CNA
6 days ago
- CNA
CNA938 Rewind - How do we undo the "knot" in private healthcare insurance?
CNA938 Rewind Play Health Minister Ong Ye Kung will work with insurers and private hospitals to create a more sustainable private healthcare financing system. He says they have gotten tied up in what he describes as a 'knot' – one that could prove detrimental to patients. Lance Alexander and Daniel Martin learn more from Dr Clive Tan, Adjunct Assistant Professor, NUS Saw Swee Hock School of Public Health. CNA938 Rewind - Water polo national team captain says World Aquatics Championship will be toughest challenge Team Singapore will field a total of 72 athletes, of which 32 will be debutants, across five disciplines in the upcoming World Aquatics Championships – Singapore 2025 – its largest ever at the sport's flagship international meet. Lance Alexander and Daniel Martin speak with Professor Kenneth Goh, President of Singapore Aquatics and Lee Kai Yang, captain of the Water Polo national team. 15 mins CNA938 Rewind - How do we undo the "knot" in private healthcare insurance? Health Minister Ong Ye Kung will work with insurers and private hospitals to create a more sustainable private healthcare financing system. He says they have gotten tied up in what he describes as a 'knot' – one that could prove detrimental to patients. Lance Alexander and Daniel Martin learn more from Dr Clive Tan, Adjunct Assistant Professor, NUS Saw Swee Hock School of Public Health. 14 mins CNA938 Rewind - The Wellness Hour - Hyperthyroidism and Graves' Disease: Can You Avoid Surgery? Unexplained weight loss, anxiety, and even bulging eyes? You might have Graves' disease, an autoimmune condition affecting the thyroid. In our third instalment, Cheryl Goh finds out why early diagnosis is key, and also looks into non-surgical treatment options with Dr Vikram Sonawane, Senior Consultant Endocrinologist and Founder of Harmony Thyroid Endocrinology and Diabetes Centre. 19 mins CNA938 Rewind - Cellography - Bringing AI & The Puppet Master to life on stage In 'Culture Club' Melanie Oliveiro speaks with the creatives involved in the production: Cellography presents 'The Puppet Master' Disney Concert. The storyline follows an old Puppet Master whose puppet magically comes to life – and soon, both begin exploring the world around them. Performed by Cellography, an all-cello pop orchestra, founder Hughes Chong and cellist Chua Siong Hoon will talk more about the plot's themes like love and courage, and how the production will unfold onstage using Artificial Intelligence. They'll also discuss the timeless Disney classics that will be performed on stage like 'When You Wish Upon a Star' and 'Can You Feel the Love Tonight'. 30 mins
